These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29623097)

  • 1. Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.
    McLaughlin MM; Guerrero AJ; Merker A
    Drugs Context; 2018; 7():212519. PubMed ID: 29623097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Tolerability of Integrase Inhibitors in Antiretroviral-Naive Patients.
    D'Abbraccio M; Busto A; De Marco M; Figoni M; Maddaloni A; Abrescia N
    AIDS Rev; 2015; 17(3):171-85. PubMed ID: 26450805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults.
    DeJesus E; Saleh S; Cheng S; van der Mey D; Becker C; Frey R; Unger S; Mueck W
    Pulm Circ; 2019; 9(2):2045894019848644. PubMed ID: 30997864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study.
    Orrell C; Hagins DP; Belonosova E; Porteiro N; Walmsley S; Falcó V; Man CY; Aylott A; Buchanan AM; Wynne B; Vavro C; Aboud M; Smith KY;
    Lancet HIV; 2017 Dec; 4(12):e536-e546. PubMed ID: 28729158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Initial antiretroviral therapy in HIV-infected patients].
    Cormier H; Hoen B
    Rev Prat; 2014 Oct; 64(8):1079-85. PubMed ID: 25510130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
    Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of antiretroviral drugs].
    Ribera E; Tuset M; Martín M; del Cacho E
    Enferm Infecc Microbiol Clin; 2011 May; 29(5):362-91. PubMed ID: 21531048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy with integrase inhibitors: more options.
    Raffi F; Wainberg MA
    Virologie (Montrouge); 2013 Apr; 17(2):54-60. PubMed ID: 31910534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice.
    McCoy C; Badowski M; Sherman E; Crutchley R; Smith E; Chastain DB;
    Pharmacotherapy; 2018 Jan; 38(1):86-107. PubMed ID: 29105160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous Occurrence of Nephrolithiasis, Fanconi Syndrome, and Nephro-osteopathy in a Patient on First-line Antiretroviral Therapy - A Case Report.
    Mangal V; Murari T; Gaikwad SN; Kaur K
    Indian J Nephrol; 2022; 32(2):175-178. PubMed ID: 35603118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
    Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?
    Cattaneo D; Minisci D; Cozzi V; Riva A; Meraviglia P; Clementi E; Galli M; Gervasoni C
    Antivir Ther; 2017; 22(4):353-356. PubMed ID: 28008867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial.
    Raffi F; Jaeger H; Quiros-Roldan E; Albrecht H; Belonosova E; Gatell JM; Baril JG; Domingo P; Brennan C; Almond S; Min S;
    Lancet Infect Dis; 2013 Nov; 13(11):927-35. PubMed ID: 24074642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
    Gallant JE; Staszewski S; Pozniak AL; DeJesus E; Suleiman JM; Miller MD; Coakley DF; Lu B; Toole JJ; Cheng AK;
    JAMA; 2004 Jul; 292(2):191-201. PubMed ID: 15249568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine and atazanavir in treatment-experienced HIV patients.
    Biagi M; Badowski ME; Chiampas T; Young J; Patel M; Vaughn P
    Int J STD AIDS; 2017 Jul; 28(8):766-772. PubMed ID: 27587601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients.
    Rho M; Perazella MA
    Curr Drug Saf; 2007 May; 2(2):147-54. PubMed ID: 18690961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine.
    Casado JL; Monsalvo M; Vizcarra P; Fontecha M; Serrano-Villar S; Moreno S
    HIV Med; 2019 Nov; 20(10):648-656. PubMed ID: 31321875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients.
    Gianotti N; Poli A; Nozza S; Galli L; Galizzi N; Ripa M; Merli M; Carbone A; Spagnuolo V; Lazzarin A; Castagna A
    BMC Infect Dis; 2017 Nov; 17(1):723. PubMed ID: 29145807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children.
    Viganò A; Aldrovandi GM; Giacomet V; Merlo M; Martelli L; Beretta S; Luraschi P; Rombolà G; Mora S
    Antivir Ther; 2005; 10(8):917-24. PubMed ID: 16430197
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.